Marek Fischer

8.6k total citations · 2 hit papers
63 papers, 6.7k citations indexed

About

Marek Fischer is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Marek Fischer has authored 63 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Virology, 43 papers in Infectious Diseases and 13 papers in Molecular Biology. Recurrent topics in Marek Fischer's work include HIV Research and Treatment (49 papers), HIV/AIDS Research and Interventions (36 papers) and HIV/AIDS drug development and treatment (34 papers). Marek Fischer is often cited by papers focused on HIV Research and Treatment (49 papers), HIV/AIDS Research and Interventions (36 papers) and HIV/AIDS drug development and treatment (34 papers). Marek Fischer collaborates with scholars based in Switzerland, United States and United Kingdom. Marek Fischer's co-authors include Charles Weissmann, Huldrych F. Günthard, Adriano Aguzzi, Rainer Weber, Hansruedi Büeler, Béda Joos, Alex J. Raeber, Hans‐Peter Lipp, Michel Aguet and Stephen J. DeArmond and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Marek Fischer

63 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein

1992 1.3k citations Hansruedi Büeler, Marek Fischer et al. Nature profile →
Normal host prion protein necessary for scrapie-induced neurotoxicity

1996 623 citations Sebastian Brandner, Stefan Isenmann et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marek Fischer Switzerland	38	3.7k	2.6k	2.0k	1.9k	1.4k	63	6.7k
Mauro C. Dal Canto United States	35	2.2k 0.6×	1.3k 0.5×	1.5k 0.8×	906 0.5×	131 0.1×	85	9.6k
Hans S.L.M. Nottet Netherlands	31	1.1k 0.3×	3.1k 1.2×	1.5k 0.7×	986 0.5×	90 0.1×	52	5.5k
Lúcio Gama United States	35	968 0.3×	1.7k 0.7×	532 0.3×	936 0.5×	198 0.1×	90	3.5k
Hermann Schätzl Germany	35	3.5k 1.0×	278 0.1×	1.4k 0.7×	296 0.2×	1.1k 0.8×	133	4.6k
Eliseo A. Eugenín United States	41	2.5k 0.7×	919 0.4×	785 0.4×	1.0k 0.5×	53 0.0×	106	5.0k
Michael A. Klein Switzerland	34	2.9k 0.8×	199 0.1×	1.5k 0.8×	169 0.1×	955 0.7×	83	4.3k
Alex J. Raeber Switzerland	30	4.9k 1.3×	162 0.1×	2.6k 1.3×	338 0.2×	1.9k 1.4×	55	5.3k
Georgina Miller United States	29	2.1k 0.6×	197 0.1×	201 0.1×	570 0.3×	544 0.4×	43	4.1k
Orna Elroy‐Stein Israel	37	3.5k 0.9×	355 0.1×	183 0.1×	417 0.2×	159 0.1×	75	5.2k
Richard Race United States	46	6.9k 1.9×	132 0.1×	3.5k 1.7×	580 0.3×	2.8k 2.0×	95	7.7k

Countries citing papers authored by Marek Fischer

Since Specialization

Citations

This map shows the geographic impact of Marek Fischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Fischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Fischer more than expected).

Fields of papers citing papers by Marek Fischer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Fischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Fischer. The network helps show where Marek Fischer may publish in the future.

Co-authorship network of co-authors of Marek Fischer

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Fischer. A scholar is included among the top collaborators of Marek Fischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Fischer. Marek Fischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gianella, Sara, Philip Rieder, Viktor von Wyl, et al.. (2010). Rational design of HIV-1 fluorescent hydrolysis probes considering phylogenetic variation and probe performance. Journal of Virological Methods. 165(2). 151–160. 24 indexed citations

Joos, Béda, Philip Rieder, Marek Fischer, et al.. (2009). Association between specific HIV-1 Env traits and virologic control in vivo. Infection Genetics and Evolution. 10(3). 365–372. 1 indexed citations

Joos, Béda, Marek Fischer, Herbert Kuster, et al.. (2008). HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proceedings of the National Academy of Sciences. 105(43). 16725–16730. 238 indexed citations

Huber, Michael, Marek Fischer, Benjamin Misselwitz, et al.. (2006). Complement Lysis Activity in Autologous Plasma Is Associated with Lower Viral Loads during the Acute Phase of HIV-1 Infection. PLoS Medicine. 3(11). e441–e441. 89 indexed citations

Trkola, Alexandra, Herbert Kuster, Peter Rusert, et al.. (2005). Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies. Nature Medicine. 11(6). 615–622. 388 indexed citations

Fischer, Marek, Béda Joos, Bernard Hirschel, et al.. (2004). Cellular Viral Rebound after Cessation of Potent Antiretroviral Therapy Predicted by Levels of Multiply Spliced HIV‐1 RNA Encodingnef. The Journal of Infectious Diseases. 190(11). 1979–1988. 53 indexed citations

Rusert, Peter, Marek Fischer, Béda Joos, et al.. (2004). Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol. Virology. 326(1). 113–129. 68 indexed citations

Fischer, Marek, Christine A. Schneider, Alexandra Trkola, et al.. (2003). HIV RNA in plasma rebounds within days during structured treatment interruptions. AIDS. 17(2). 195–199. 68 indexed citations

Bonhoeffer, Sebastian, Georg A. Funk, Huldrych F. Günthard, Marek Fischer, & Viktor Müller. (2003). Glancing behind virus load variation in HIV-1 infection. Trends in Microbiology. 11(11). 499–504. 46 indexed citations

10.

Schüpbach, Jörg, Jürg Böni, Leslie R. Bisset, et al.. (2003). HIV-1 p24 Antigen Is a Significant Inverse Correlate of CD4 T-Cell Change in Patients With Suppressed Viremia Under Long-Term Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 33(3). 292–299. 35 indexed citations

11.

Oxenius, Annette, David A. Price, Sara J. Dawson, et al.. (2002). Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load. AIDS. 16(17). 2317–2322. 18 indexed citations

12.

Opravil, Milos, Bernard Hirschel, Adriano Lazzarin, et al.. (2002). A Randomized Trial of Simplified Maintenance Therapy with Abacavir, Lamivudine, and Zidovudine in Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 185(9). 1251–1260. 106 indexed citations

13.

Oxenius, Annette, David A. Price, Huldrych F. Günthard, et al.. (2002). Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection. Proceedings of the National Academy of Sciences. 99(21). 13747–13752. 177 indexed citations

14.

Funk, Georg A., Marek Fischer, Béda Joos, et al.. (2001). Quantification of In Vivo Replicative Capacity of HIV-1 in Different Compartments of Infected Cells. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(5). 397–404. 38 indexed citations

15.

Bisset, Leslie R., Richard W. Cone, Marek Fischer, et al.. (2001). Long-Term Evaluation of T-Cell Subset Changes After Effective Combination Antiretroviral Therapy During Asymptomatic HIV-Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 27(3). 266–271. 1 indexed citations

16.

Fischer, Marek, Huldrych F. Günthard, Milos Opravil, et al.. (2000). Residual HIV-RNA Levels Persist for Up to 2.5 Years in Peripheral Blood Mononuclear Cells of Patients on Potent Antiretroviral Therapy. AIDS Research and Human Retroviruses. 16(12). 1135–1140. 46 indexed citations

17.

Opravil, Milos, Richard W. Cone, Marek Fischer, et al.. (2000). Effects of Early Antiretroviral Treatment on HIV-1 RNA in Blood and Lymphoid Tissue: A Randomized Trial of Double Versus Triple Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(1). 17–25. 28 indexed citations

18.

Lipp, Hans‐Peter, et al.. (1998). A 2-year longitudinal study of swimming navigation in mice devoid of the prion protein: no evidence for neurological anomalies or spatial learning impairments. Behavioural Brain Research. 95(1). 47–54. 21 indexed citations

19.

Brandner, Sebastian, Stefan Isenmann, Alex J. Raeber, et al.. (1996). Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature. 379(6563). 339–343. 623 indexed citations breakdown →

20.

Weissmann, Charles, Hansruedi Büeler, Marek Fischer, & Michel Aguet. (1993). Role of the PrP Gene in Transmissible Spongiform Encephalopathies. Intervirology. 35(1-4). 164–175. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact